|Keywords:||cat, hcm, cardiomyopathy, subclinical, hypertrophic cardiomyopathy|
|Type:||Clinical Drug Trial|
This is a six month clinical trial and consists of four visits in-person, at enrollment, 2 months, 4 months, and six months. The is a drug trial and cats will receive either the study drug (rapamycin) or placebo once weekly by mouth for the entire six months.
Pet owners will be responsible for bringing their cat in for each scheduled visit (minimum of four) and administration of the once weekly medication for the six month period.
Eligible: Cats with HCM that are otherwise healthy. Must be <12 yrs of age and weigh 7.7lbs or more.
Ineligible: Cats with congestive heart failure, hypertension, chronic kidney disease, anemia or other serious illness requiring ongoing medication that alters cardiac function.
To determine eligibility, we will need:
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.